期刊文献+

血浆D-二聚体水平变化在心脏房颤血栓前状态诊断的意义 被引量:1

The significance of changes of plasma D-dimer level in diangnosis of atrial fibrillation
下载PDF
导出
摘要 目的探讨房颤持续时间与复律前后血浆D-二聚体水平的变化关系。方法将42例心脏房颤病人分成A、B两组,A组房颤持续时间为72h或以上(142.7±103.8h),B组房颤持续时间少于72h(25±16h)。以酶免疫法测定对复律前和复律后36h的血浆D-二聚体水平,并与19例对照组比较。结果与对照组相比,A、B两组病例复律前血浆D-二聚体水平均明显增高(P<0.05),并与房颤持续时间有显著相关。结论房颤持续时间越长,复律后血栓前状态越明显;房颤持续时间和D-二聚体水平可作为房颤复律血栓前状态的新的预测物。 Objective To incestigate whether the duration of atrid fibrillation influences the haemostasis measured by plasma D - dimer levels. Methods 42 patients wirh atrial fibrillation undergoing cardioversion wert divided into two groupo : In Gronp A( n =24,14male,56 ± 11years) the duration of atrial fibrillation was 72 hours or more (142.7 ± 103.8hours),in Group B(n = 18, 10male,61 ± 13years)the duration of atrid fibrillation was less than 72 hours (25 ± 16hours). plasma D - dimer levels 36hours after cardioversion was calculated as △ D - dimer. Results Compared to the Control, the baseline D - dimer levels were significantly higher in both groups. The absolute values of △ - D - dimer levels were significantlg higher in Group A than in group B ( P 〈 0. 005). Conclusion Furthermore, plasma D- dimer levels 36hours after condioversion(R = 0.52, P = 0.0016)and △ - D - dimer levels (R = 0.73, P 〈 0.0001 )showed sisnificant correlations with the duration of atrial fibrillation episode conld lead to a more prominent prothrombotic state . the duration of the atrial fibrillation episode and △- D - dimer levels conld be used as the useful clinical markers of the prothrombotic state after successful cardioversion.
出处 《中国热带医学》 CAS 2006年第8期1422-1423,共2页 China Tropical Medicine
关键词 房颤 心电复律 D-二聚体 Atrial fibrillation cardioversion D - dimer
  • 相关文献

参考文献3

  • 1Bounameaux H,cirafici P,de Moerloose P,et al.Measurement of Ddimer in plasma as diagnostic aid in suspected pulmonary embolism[J].Lancet,1991,337:196 ~ 250.
  • 2Kelly h,Rudd A,Lewis R,et al.Plasma D -dimers in the diagnosis of venous thromboembolism[J].Arch Int Med,2002,162:747 ~ 756.
  • 3Lip GYH,Rumley A,Dunn FG,et al.Plasma fibrinogen and D -dimer levels in atrial fibrillation effect of cardioversion to sinus rhymth[J].Int J Cardiol,1995,51:245 ~ 253.

同被引文献14

  • 1吴俊,于贵杰,许俊堂.非瓣膜性心房颤动高凝状态指标及抗栓治疗监测[J].中国医药导刊,2006,8(4):266-269. 被引量:5
  • 2李曦,谢英,赵瑞祥,张维君,温绍君,周玉杰,张妍,程秀琴,张文,彭新界,王龙华,刘洁琳,郭永和.阿司匹林或华法林治疗对非瓣膜病持续性心房颤动患者凝血-纤溶指标影响及安全性[J].临床心血管病杂志,2007,23(10):754-758. 被引量:9
  • 3MARIN ORTUNO F, ROI.DAN SCHII.LING V, MAR- CO VERA P, et al. Improvement in fibrinolyticfunction following anticoagulant treatment in chronic rtheumatic at rial fibrillation[J]. Rev Esp Cardion, 1999,52 : 25- 30.
  • 4DE BON() D. Significance of raised plasma concentra tions of tissue-type plasminogen activator and plas minogen activator inhibitor in patients at risk from is chaemic heart disease[J].Br Heart J,1994,71:504- 507.
  • 5HAMSTER A. Hemostatic function and coronary ar tery disease[J]. N EnglJ Med,1995,332:667-668.
  • 6MITUSCH R, SIEMENS H J, GARBE M, el al. Detection of a hypercoagulable state in nonvalvular at rial fibrillation and the effect of anticoagulant therapy [J]. Thromb Haemost,1996,75:219-223.
  • 7ROLDAN V, MARIN F, MARCO P, et al. Antico- agulant therapy modifies fibrinolytic dysfunction in chronic atrial fibrillationEJ2. Haemostasis, 2000,30: 219-224.
  • 8LI-SAW HEE F I., BLANN A D, I.IP G Y. Effects of fixed low dose warfarin, aspirin-warfarin combina- tion therapy, and dose adjusted warfarin on thrombo- genesis in chronic atrial fibrillation[J]. Stroke, 2000, 31 :828-833.
  • 9MAHE I, DROUET I., CHASSANY O, et al. D-di- mer: a characteristic of the coagulation state of each patient with chronic atrial fibrillation [J]. Thromb Res,2002,107:1-6.
  • 10ENTA K, IWADE K, AOSAKI M, et al. Predictive vale of Coagulative molecularmarkers for thromboem- bolism in patientswith nonvalvular atrial fibrillation: prospective five year follow up study[J]. J Cardiol, 2004,44:223-232.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部